Hypermutation as a potential predictive biomarker of immunotherapy efficacy in high-grade gliomas: a broken dream?

Immunotherapy, Ahead of Print.

Source: Immunotherapy - June 7, 2022 Category: Allergy & Immunology Authors: Lidia Gatto Enrico Franceschi Alicia Tosoni Vincenzo Di Nunno Stefania Bartolini Alba Ariela Brandes Source Type: research